Juvenile Myelomonocytic Leukemia - 20 Studies Found
| Not yet recruiting |
: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) :
|
| Active, not recruiting |
: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies :
|
| Recruiting |
: Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies :
|
| Completed |
: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors :
|
| Withdrawn |
: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) :
|
| Completed |
: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant :
|
| Terminated |
: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant :
|
| Completed |
: Stem Cell Transplantation for Patients With Hematologic Malignancies :
|
| Completed |
: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies :
|